2019 Archives presentations

You can find the presentations that were given at workshops and symposia at the FAMHP here.

“Working together with and for the patient” symposium – 10 december 2019

Patient engagement and Patient Expert Centre – Erik Briers (PEC)
Betrokkenheid van de patiënt in nationale aanvragen voor Scientific-Technical Advice betreffende klinische roeven : FAGG Pilootproject – Christophe Lahorte (FAMHP)
Toekomstige betrokkenheid van de patiënt in de beoordeling van aanvragen voor klinische proeven – Voorstelling van het toekomstig pilootproject van het FAGG – Pieter Vankeerberghen (FAMHP)
Betrokkenheid van de patiënt in de ontwikkeling van de Informed Consent Form (ICF): een korte update – Katelijne Anciaux (FPS HFCSE), Anneleen Lintermans (Vlaams Patiëntenplatform)
Patiënten betrekken bij beleidsvoorbereidend onderzoek in de gezondheidszorg - Standpunten van het KCE - Irina Cleemput (KCE)
Experiences with patient involvement in KCE Trials Funding Programme – France Vrijens (KCE)
Safe and timely access to medicinal products - Role of the FAMHP in the EU-regulatory framework – Greet Musch (FAMHP)
Rol van het RIZIV in de terugbetaling van innovatieve geneesmiddelen en therapieën: leidraad voor de patiënt - Francis Arickx (RIZIV-INAMI)

Vaccine Symposium - December 6 december 2019

Pertussis vaccines: from whole cell to acellular vaccines and why better vaccines are still needed - Camille Locht (Institut national de la santé et de la recherche médicale – INSERM)
Ebola and vaccine emergency access in Europe and western countries - Nele Berthels (FAMHP)
Shingrix as a case study to illustrate marketing authorisation procedure - Didier Hue (FAMHP)
Quality requirement for vaccines and future perspective - Koen Brusselmans (Sciensano)
FAMHP vaccine news - Stéphanie Mali (FAMHP)
Adverse events following immunisation: from their notification to their interpretation - Françoise Wuillaume (FAMHP)
Tuberculosis vaccines: rising opportunities - Johan Vekemans (World Health Organisation - WHO)
Implementation of vaccination program in Belgium - Paloma Carrillo (Office de la Naissance et de l'Enfance - ONE) Geert Top (Agentschap Zorg en Gezondheid - Vlaanderen)
Societal impact of vaccination: beyond individual protection - Nicolas Dauby (CHU Saint-Pierre/UMC Sint-Pieter)
Polio eradication: what is needed to eradicate polio? Where are we now in Belgium? - Charles Denonne (Federal Public Service Health, Food Chain Safety and Environment)
Epidemiologic surveillance to inform and assess Belgium’s vaccine policies: strengths and challenges - Chloé Wyndham-Thomas (Sciensano)

Symposium on the new European legislation on veterinary medicines - 19 novembre 2019

- The new European legislation

- General framework - Herlinde Sleurs (project manager - FAMHP)

- Drug surveillance - Els Dewaele (expert in drug surveillance - FAMHP)

- Application procedures and file requirements - Irma van Deurzen (managing director - Dopharma Research)

- Variations and Union Database - Katelijne Smets (Global Regulatory Affairs and Product Development Director - KELA nv)

- SPC Harmonisation - Dries Minne (Head of Medicines for Veterinary Use Division - FAMHP)

- Outlook & Question Round - Dries Minne (Head of Medicines for Veterinary Use Division - FAMHP)

- Regulation from a European perspective - Nancy De Briyne (Deputy Executive Director - Federation of Veterinarians of Europe)

- Regulation of medicated feeds - Quentin Dumont de Chassart (attaché expert in animal feeds - FPS Public Health, Safety of the Food Chain and Living Environment)

The veterinary drug regulations - General framework - Herlinde Sleurs (project manager - FAMHP)

- The veterinary drug regulations - What changes for the veterinarians? - Dominique Gillard (depot inspector - FAMHP)

- Antibiotic resistance - Bart Hoet (attaché of the Medicines for Veterinary Use Division - FAMHP)